The ROE as of September 2024 (TTM) for Longboard Pharmaceuticals, Inc. (LBPH) is -36.93%

According to Longboard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -36.93%. This represents a change of 100.25% compared to the average of -18.44% of the last 4 quarters.

Longboard Pharmaceuticals, Inc. (LBPH) Historical ROE (quarterly & annually)

How has LBPH ROE performed in the past?

The mean historical ROE of Longboard Pharmaceuticals, Inc. over the last ten years is -64.26%. The current -36.93% ROE has changed -42.54% with respect to the historical average. Over the past ten years (40 quarters), LBPH's ROE was at its highest in in the September 2020 quarter at 270.41%. The ROE was at its lowest in in the December 2023 quarter at -36.73%.

Longboard Pharmaceuticals, Inc. (LBPH) ROE by Quarter and Year

Discovering the peaks and valleys of Longboard Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Longboard Pharmaceuticals, Inc. (LBPH) Average ROE

How has LBPH ROE performed in the past?

The current ROE of Longboard Pharmaceuticals, Inc. (LBPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Longboard Pharmaceuticals, Inc. (LBPH) ROE vs. Peers

How is LBPH’s ROE compared to its peers?

Longboard Pharmaceuticals, Inc.’s ROE is greater than Molecular Partners AG (-33.08%), greater than MediciNova, Inc. (-13.37%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), less than Champions Oncology, Inc. (1.48%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Decibel Therapeutics, Inc. (-84.03%), greater than Celcuity Inc. (-60.83%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Assembly Biosciences, Inc. (-121.55%), greater than NextCure, Inc. (-57.63%), greater than Nuvation Bio Inc. (-98.79%), greater than Graphite Bio, Inc. (-57.96%), greater than Instil Bio, Inc. (-55.57%), greater than Sensei Biotherapeutics, Inc. (-48.14%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Ikena Oncology, Inc. (-42.81%), greater than Stoke Therapeutics, Inc. (-57.89%),

Build a custom stock screener for Longboard Pharmaceuticals, Inc. (LBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longboard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Longboard Pharmaceuticals, Inc. (LBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Longboard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.